(50 days)
Not Found
No
The summary describes standard image processing, visualization, and reporting functionalities without mentioning AI, ML, or related concepts like training/test sets for algorithmic learning.
No.
The device is a software application designed for viewing, quantifying, and analyzing image data from ultrasound products. It does not exert any direct therapeutic effect on a patient.
Yes
The device assists in the visualization, analysis, and reporting of ultrasound vascular images by segmenting, measuring, and annotating regions of interest, and generating reports of user inputs, all of which support medical professionals in making diagnoses.
Yes
The device is explicitly described as a "software application package" and its function is to process and analyze image data acquired from commercially available ultrasound products. It does not include any hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device function: Visualize: Vascular is a software application that processes and analyzes image data acquired from ultrasound products. It does not interact with or analyze biological specimens.
- Intended Use: The intended use is to "view and quantify image data acquired on commercially available ultrasound products." This is focused on image processing and analysis, not on testing biological samples.
Therefore, Visualize: Vascular falls under the category of medical imaging software, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
Visualize: Vascular is a software application package. It is designed to view and quantify image data acquired on commercially available ultrasound products. Regions of interest can be segmented, measured and annotated. The results can be displayed in 2D or 3D. The system automatically generates reports of user inputs.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
Visualize: Vascular™ 1.0 is a software application designed to assist in visualization, analysis and reporting of ultrasound vascular images. All images acquired for use with Visualize must be obtained using the data acquisition protocol found in the Visualize: Vascular User Guide.
Visualize: Vascular displays cine clips in stack mode, which can be viewed going forward and in reverse. When the user selects a region(s) of interest within the cine clips, Visualize provides a 3D volume reconstruction and surface rendering of the segmented information. The user can manipulate and annotate the 3D reconstructed images. Visualize can also map the cine colour flow information provided by the ultrasound system onto the 3D rendered data. Visualize provides an automated method to measure the narrowest and widest sections of segmented areas.
Visualize: Vascular displays 2D sagittal ultrasound images and provides a manual tool for measurements to be recorded on these 2D images.
The software application automatically generates reports from user inputs annotated during the image analysis process. The user may select the images, measurements and clinical findings to display in the report. All fields may be modified by the user at any time during the analysis and prior to archiving.
An output may be viewed and sent to standard film or paper printers or sent electronically to an intranet web server or other DICOM device. The software may retrieve archived reports from a web server or other DICOM device.
The Visualize software is a Windows 7, DICOM-compatible platform that may be installed on a standalone PC, PACS, imaging system or embedded in software applications cleared for use in medical imaging. The Medipattern software is designed to be compatible with any of the DICOM-compliant medical devices distributed by various OEM ultrasound equipment manufacturers.
Visualize: Vascular is a software application package. It is designed to view and quantify image data acquired on commercially available ultrasound products. Regions of interest can be segmented, measured and annotated. The results can be displayed in 2D or 3D. The system automatically generates reports of user inputs.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
ultrasound
Anatomical Site
vascular
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
"Functional/Safety Testing: Visualize: Vascular has successfully undergone functional testing. This product has been shown to be equivalent to the predicate devices."
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K021966, K040227, K022824, K040546
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
5 510(k) Summary
| Submitter: | The Medipattern Corporation
3080 Yonge Street, Suite 4070
Toronto, Ontario, Canada M4N 3N1 |
|-------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Erin Walsh
Regulatory and Quality Manager |
| Date Prepared: | December 22, 2010 |
| Trade name: | Visualize:Vascular |
| Classification
Name: | Archiving and Communications Workstation
(21 CFR 892.2050) |
| Product Code: | LLZ |
| Panel: | Radiology |
| Predicate Devices: | 1. Philips QLab; cleared under K021966 and K040227
2. TomTec Echo-View; cleared under K022824 and K040546 |
| Device
Description: | Visualize: Vascular™ 1.0 is a software application designed to
assist in visualization, analysis and reporting of ultrasound
vascular images. All images acquired for use with Visualize
must be obtained using the data acquisition protocol found in
the Visualize: Vascular User Guide.
Visualize: Vascular displays cine clips in stack mode, which can
be viewed going forward and in reverse. When the user selects
a region(s) of interest within the cine clips, Visualize provides a
3D volume reconstruction and surface rendering of the
segmented information. The user can manipulate and annotate
the 3D reconstructed images. Visualize can also map the cine
colour flow information provided by the ultrasound system onto
the 3D rendered data. Visualize provides an automated method
to measure the narrowest and widest sections of segmented
areas. |
Original 510(k) PreMarket Notification Visualize:Vascular
:
.
:
.
·
,
.
・・
. . . .
:
.
・
.
:
1
Visualize: Vascular displays 2D sagittal ultrasound images and provides a manual tool for measurements to be recorded on these 2D images.
The software application automatically generates reports from user inputs annotated during the image analysis process. The user may select the images, measurements and clinical findings to display in the report. All fields may be modified by the user at any time during the analysis and prior to archiving.
An output may be viewed and sent to standard film or paper printers or sent electronically to an intranet web server or other DICOM device. The software may retrieve archived reports from a web server or other DICOM device.
The Visualize software is a Windows 7, DICOM-compatible platform that may be installed on a standalone PC, PACS, imaging system or embedded in software applications cleared for use in medical imaging. The Medipattern software is designed to be compatible with any of the DICOM-compliant medical devices distributed by various OEM ultrasound equipment manufacturers.
Visualize: Vascular is a software application package. It is designed to view and quantify image data acquired on commercially available ultrasound products. Regions of interest can be segmented, measured and annotated. The results can be displayed in 2D or 3D. The system automatically generates reports of user inputs.
Comparative Visualize: Vascular has been demonstrated to be as safe and Analysis: effective as the predicate devices for their intended use.
Functional/Safety Visualize: Vascular has successfully undergone functional testing. This product has been shown to be equivalent to the predicate devices.
Conclusion:
Testing:
Intended Use:
Visualize: Vascular is substantially equivalent to the predicate devices.
Original 510(k) PreMarket Notification Visualize:Vascular
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines forming its body and wings. The eagle is enclosed in a circle, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is written around the circle. The text is in all caps and is arranged to follow the curve of the circle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Ms. Erin Walsh Regulatory and Quality Manager The Medipattern Corporation 3080 Yonge Street, Suite 4070 Toranto, Ontario, M4N 3N1 CANADA
FEB 1 1 2011
Re: K103761
Trade/Device Name: Visualize: Vascular™ Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: II Product Code: LLZ Dated: December 22, 2010 Received: December 23, 2010
Dear Ms. Walsh:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean. that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting of
3
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours.
Mary S Pastel
Mary Pastel, ScD. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
4
Indications for Use Statement
510(k) Number (if known):
Device Name: Visualize:Vascular™
Indications for Use:
Visualize: Vascular is a software application package. It is designed to view and quantify image data acquired on commercially available ultrasound products. Regions of interest can be segmented, measured and annotated. The results can be displayed in 2D or 3D. The system automatically generates reports of user inputs.
Prescription Use X AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation: (000E) CV
Mary S. Padelf.
(Division Sign-Off) Division of Aadiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety
510K Kib3761
Original 510(k) PreMarket Notification Visualize:Vascular
Page 12